Thrombopoietin Receptor Levels in Tumor Cell Lines and Primary Tumors

Thrombopoietin (TPO) receptor agonists represent a new approach for the treatment of thrombocytopenia, which may develop as a consequence of immune thrombocytopenia, chemotherapy treatment, chronic hepatitis C infection, or myelodysplastic syndromes. There are concerns that use of certain growth fac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Erickson-Miller, Connie L., Chadderton, Antony, Gibbard, Anna, Kirchner, Jennifer, Pillarisetti, Kodandaram, Baker, Katherine, Pandite, Lini, El-Hariry, Iman, Mostafa Kamel, Yasser, Liu, Yuan, Martin, Anne-Marie, Messam, Conrad
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3026977/
https://ncbi.nlm.nih.gov/pubmed/21318160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/135354
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados